(Q45071656)

English

Salvage surgical resection after high-dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS): a potential positive selection bias--a study of the Spanish group for research on sarcomas (GEIS).

scientific article published in October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Salvage surgical resection after high-dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS): a potential positive selection bias--a study of the Spanish group for research on sarcomas (GEIS) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Joan Maurel

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

José Buesa

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Antonio López-Pousa

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Xavier García del Muro

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

María Jesús Quintana

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Javier Martín

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Antonio Casado

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Javier Martínez-Trufero

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Ramón de Las Peñas

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 October 2004

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Journal of Surgical Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

88

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

44-49

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FJSO.20131

21 January 2018

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1002%2FJSO.20131

21 January 2018

High-dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: is it feasible?

1 reference

https://api.crossref.org/works/10.1002%2FJSO.20131

21 January 2018

Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.20131

21 January 2018

Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and

1 reference

https://api.crossref.org/works/10.1002%2FJSO.20131

21 January 2018

Identifiers

10.1002/JSO.20131

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

release_6fje47yicvghrbuc7z3r2ab5a4

1 reference

https://api.fatcat.wiki/v0/release/6fje47yicvghrbuc7z3r2ab5a4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15384088%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45071656&oldid=1844314957"